Cargando…
A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury
OBJECTIVE: Acute kidney injury (AKI) is a highly morbid condition in critically ill patients that is associated with high mortality. Previous clinical studies have demonstrated the safety and efficacy of the Selective Cytopheretic Device (SCD) in the treatment of AKI requiring continuous renal repla...
Autores principales: | Tumlin, James A., Galphin, Claude M., Tolwani, Ashita J., Chan, Micah R., Vijayan, Anitha, Finkel, Kevin, Szamosfalvi, Balazs, Dev, Devasmita, DaSilva, J. Ricardo, Astor, Brad C., Yevzlin, Alexander S., Humes, H. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526678/ https://www.ncbi.nlm.nih.gov/pubmed/26244978 http://dx.doi.org/10.1371/journal.pone.0132482 |
Ejemplares similares
-
Use of the Selective Cytopheretic Device in Critically Ill Children
por: Goldstein, Stuart L., et al.
Publicado: (2020) -
Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
por: Tumlin, James, et al.
Publicado: (2017) -
Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure
por: Humes, H. David, et al.
Publicado: (2023) -
Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1
por: Tumlin, J. A., et al.
Publicado: (2013) -
Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
por: Yessayan, Lenar T., et al.
Publicado: (2022)